Tenet Healthcare Corp. Enters Material Definitive Agreement

Ticker: THC · Form: 8-K · Filed: Nov 5, 2025 · CIK: 70318

Sentiment: neutral

Topics: material-definitive-agreement, financial-obligation

TL;DR

Tenet Healthcare just signed a big deal, could be good or bad for the stock.

AI Summary

On November 4, 2025, Tenet Healthcare Corporation entered into a material definitive agreement related to financial obligations. The company, formerly known as National Medical Enterprises Inc., is incorporated in Nevada and its fiscal year ends on December 31.

Why It Matters

This filing indicates a significant financial transaction or commitment by Tenet Healthcare, which could impact its financial standing and future operations.

Risk Assessment

Risk Level: medium — Entering into material definitive agreements can introduce new financial risks or opportunities, requiring further analysis.

Key Players & Entities

FAQ

What specific type of material definitive agreement did Tenet Healthcare Corporation enter into?

The filing states that the company entered into a 'Material Definitive Agreement' and also notes 'Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant', but does not specify the exact nature of the agreement.

What is the exact date of the earliest event reported in this 8-K filing?

The date of the earliest event reported is November 4, 2025.

What was Tenet Healthcare Corporation's former company name?

Tenet Healthcare Corporation's former name was National Medical Enterprises Inc. /NV/.

In which state is Tenet Healthcare Corporation incorporated?

Tenet Healthcare Corporation is incorporated in Nevada.

What is the IRS Employer Identification Number (EIN) for Tenet Healthcare Corporation?

The IRS Employer Identification Number for Tenet Healthcare Corporation is 95-2557091.

Filing Stats: 1,350 words · 5 min read · ~5 pages · Grade level 12.9 · Accepted 2025-11-05 16:05:49

Key Financial Figures

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1* Credit Agreement, dated as of November 4, 2025, by and among Tenet Healthcare Corporation, the lenders and issuers party thereto and JPMorgan Chase Bank, N.A., as administrative agent. 10.2* Amendment No. 7, dated as of November 4, 2025, to the Letter of Credit Facility Agreement, dated as of March 7, 2014, by and among Tenet Healthcare Corporation, the LC participants and issuers party thereto and Barclays Bank PLC, as administrative agent. 104 Cover Page Interactive Data File (embedded within the inline XBRL document). * Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The descriptions of the omitted schedules and exhibits are contained within the ABL Agreement and the LC Amendment. Tenet hereby agrees to furnish a copy of any omitted schedule or exhibit to the Securities and Exchange Commission upon request. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TENET HEALTHCARE CORPORATION Date: November 5, 2025 By: /s/ Thomas Arnst Name: Thomas Arnst Title: Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing